Robert E. Gagnon Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert E. Gagnon.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert E. Gagnon. Robert E. Gagnon is EVP CFO and Treasurer in CLEAN HARBORS INC ($CLH) and Chief Acct Officer VP & Contr in BIOGEN INC. ($IDPH) and Vice President, Finance in BIOGEN INC. ($IDPH) and Chief Financial Officer in HARVARD BIOSCIENCE INC ($HBIO) and Chief Financial Officer in Verastem, Inc. ($VSTM).
Latest Insider Trading Transactions of Robert E. Gagnon
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IDPH, CLH, HBIO, VSTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22 2020 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | A | 2.20 | 203,776 | 448,307 | 203,776 | |
| Dec 22 2020 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 67,925 | 0 | 571,635 | 503.7 K to 571.6 K (+13.48 %) |
| Aug 13 2020 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 290,210 | 0 | 503,710 | 213.5 K to 503.7 K (+135.93 %) |
| Mar 30 2020 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 62,500 | 0 | 213,500 | 151 K to 213.5 K (+41.39 %) |
| Mar 30 2020 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 62,500 | 0 | 213,500 | 151 K to 213.5 K (+41.39 %) |
| Dec 17 2019 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | A | 1.34 | 125,000 | 167,500 | 125,000 | |
| Dec 17 2019 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | A | 1.34 | 125,000 | 167,500 | 125,000 | |
| Jun 25 2019 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | A | 1.81 | 250,000 | 452,500 | 250,000 | |
| Jun 25 2019 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | A | 1.81 | 250,000 | 452,500 | 250,000 | |
| Jun 25 2019 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 100,000 | 0 | 151,000 | 51 K to 151 K (+196.08 %) |
| Jun 25 2019 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 100,000 | 0 | 151,000 | 51 K to 151 K (+196.08 %) |
| Jan 07 2019 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | A | 3.51 | 50,000 | 175,500 | 50,000 | |
| Jan 07 2019 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | A | 3.51 | 50,000 | 175,500 | 50,000 | |
| Aug 30 2018 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | A | 9.43 | 350,000 | 3,300,500 | 350,000 | |
| Aug 30 2018 | VSTM | Verastem, Inc. | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 50,000 | 0 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Aug 30 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.77 | 8,889 | 51,290 | 321,169 | 330.1 K to 321.2 K (-2.69 %) |
| Aug 13 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Payment of Exercise | F | 5.70 | 5,170 | 29,469 | 330,058 | 335.2 K to 330.1 K (-1.54 %) |
| Aug 09 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 5.56 | 37,500 | 208,500 | 12,500 | |
| Aug 09 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.12 | 20,000 | 82,400 | 0 | |
| Aug 09 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.31 | 30,000 | 129,300 | 0 | |
| Aug 09 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 6.08 | 100,015 | 608,091 | 349,286 | 449.3 K to 349.3 K (-22.26 %) |
| Aug 09 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 5.56 | 37,500 | 208,500 | 449,301 | 411.8 K to 449.3 K (+9.11 %) |
| Aug 09 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.12 | 20,000 | 82,400 | 411,801 | 391.8 K to 411.8 K (+5.10 %) |
| Aug 09 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.31 | 30,000 | 129,300 | 391,801 | 361.8 K to 391.8 K (+8.29 %) |
| Jul 31 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.12 | 20,000 | 82,400 | 20,000 | |
| Jul 31 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.31 | 30,000 | 129,300 | 30,000 | |
| Jul 31 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.54 | 62,514 | 346,328 | 361,801 | 424.3 K to 361.8 K (-14.73 %) |
| Jul 31 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.12 | 20,000 | 82,400 | 424,315 | 404.3 K to 424.3 K (+4.95 %) |
| Jul 31 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.31 | 30,000 | 129,300 | 404,315 | 374.3 K to 404.3 K (+8.01 %) |
| Jul 26 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.25 | 5,570 | 29,243 | 374,315 | 379.9 K to 374.3 K (-1.47 %) |
| Jul 23 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.25 | 1,465 | 7,691 | 379,885 | 381.4 K to 379.9 K (-0.38 %) |
| Jul 23 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.25 | 1,100 | 5,775 | 381,350 | 382.5 K to 381.4 K (-0.29 %) |
| Jul 16 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.12 | 5,828 | 24,011 | 40,000 | |
| Jul 16 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.25 | 1,062 | 5,576 | 382,450 | 383.5 K to 382.5 K (-0.28 %) |
| Jul 16 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.25 | 9,145 | 48,011 | 383,512 | 392.7 K to 383.5 K (-2.33 %) |
| Jul 16 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.12 | 5,828 | 24,011 | 392,657 | 386.8 K to 392.7 K (+1.51 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.12 | 54,172 | 223,189 | 45,828 | |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.31 | 62,100 | 267,651 | 60,000 | |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.31 | 13,700 | 59,047 | 122,100 | |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.31 | 14,200 | 61,202 | 135,800 | |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.23 | 141,300 | 738,999 | 386,829 | 528.1 K to 386.8 K (-26.75 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.12 | 54,172 | 223,189 | 528,129 | 474 K to 528.1 K (+11.43 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.31 | 62,100 | 267,651 | 473,957 | 411.9 K to 474 K (+15.08 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.12 | 54,172 | 223,189 | 45,828 | |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.38 | 13,700 | 73,706 | 411,857 | 425.6 K to 411.9 K (-3.22 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.31 | 62,100 | 267,651 | 60,000 | |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.31 | 13,700 | 59,047 | 425,557 | 411.9 K to 425.6 K (+3.33 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.31 | 13,700 | 59,047 | 122,100 | |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.41 | 14,200 | 76,822 | 411,857 | 426.1 K to 411.9 K (-3.33 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | M | 4.31 | 14,200 | 61,202 | 135,800 | |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.31 | 14,200 | 61,202 | 426,057 | 411.9 K to 426.1 K (+3.45 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.23 | 141,300 | 738,999 | 386,829 | 528.1 K to 386.8 K (-26.75 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.12 | 54,172 | 223,189 | 528,129 | 474 K to 528.1 K (+11.43 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.31 | 62,100 | 267,651 | 473,957 | 411.9 K to 474 K (+15.08 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.38 | 13,700 | 73,706 | 411,857 | 425.6 K to 411.9 K (-3.22 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.31 | 13,700 | 59,047 | 425,557 | 411.9 K to 425.6 K (+3.33 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 5.41 | 14,200 | 76,822 | 411,857 | 426.1 K to 411.9 K (-3.33 %) |
| Jul 11 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | M | 4.31 | 14,200 | 61,202 | 426,057 | 411.9 K to 426.1 K (+3.45 %) |
| May 29 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 40,000 | 0 | 411,857 | 371.9 K to 411.9 K (+10.76 %) |
| May 29 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 40,000 | 0 | 371,857 | 331.9 K to 371.9 K (+12.05 %) |
| May 08 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Payment of Exercise | F | 5.00 | 26,081 | 130,405 | 331,857 | 357.9 K to 331.9 K (-7.29 %) |
| Mar 12 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Sell | S | 4.62 | 97,087 | 448,542 | 357,938 | 455 K to 357.9 K (-21.34 %) |
| Jan 04 2018 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Payment of Exercise | F | 3.30 | 20,048 | 66,158 | 455,025 | 475.1 K to 455 K (-4.22 %) |
| May 30 2017 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | P | 2.33 | 1,000 | 2,330 | 475,073 | 474.1 K to 475.1 K (+0.21 %) |
| May 30 2017 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 108,696 | 0 | 474,073 | 365.4 K to 474.1 K (+29.75 %) |
| May 30 2017 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 108,696 | 0 | 365,377 | 256.7 K to 365.4 K (+42.35 %) |
| Jan 04 2017 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Payment of Exercise | F | 3.05 | 10,868 | 33,147 | 256,681 | 267.5 K to 256.7 K (-4.06 %) |
| Nov 03 2016 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | P | 2.34 | 20,000 | 46,800 | 267,549 | 247.5 K to 267.5 K (+8.08 %) |
| Nov 03 2016 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | P | 2.33 | 5,000 | 11,650 | 247,549 | 242.5 K to 247.5 K (+2.06 %) |
| May 10 2016 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 88,652 | 0 | 242,549 | 153.9 K to 242.5 K (+57.60 %) |
| May 10 2016 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 88,652 | 0 | 153,897 | 65.2 K to 153.9 K (+135.88 %) |
| Jan 05 2016 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Payment of Exercise | F | 3.47 | 2,476 | 8,592 | 65,245 | 67.7 K to 65.2 K (-3.66 %) |
| Nov 16 2015 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | P | 2.93 | 1,500 | 4,395 | 67,721 | 66.2 K to 67.7 K (+2.27 %) |
| Nov 09 2015 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Buy | P | 3.08 | 3,000 | 9,240 | 66,221 | 63.2 K to 66.2 K (+4.75 %) |
| Aug 05 2015 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 28,117 | 0 | 63,221 | 35.1 K to 63.2 K (+80.10 %) |
| Jun 08 2015 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Option Exercise | A | 5.56 | 50,000 | 278,000 | 50,000 | |
| Jun 08 2015 | HBIO | HARVARD BIOSCIENCE ... | Gagnon Robert E. | Chief Financial Off ... | Grant | A | 0.00 | 26,500 | 0 | 35,104 | 8.6 K to 35.1 K (+308.00 %) |
| Sep 13 2012 | CLH | CLEAN HARBORS INC | Gagnon Robert E. | EVP CFO and Treasur ... | Grant | A | 0.00 | 1,392 | 0 | 7,386 | 6 K to 7.4 K (+23.22 %) |
| Sep 13 2012 | CLH | CLEAN HARBORS INC | Gagnon Robert E. | EVP CFO and Treasur ... | Grant | A | 0.00 | 994 | 0 | 5,994 | 5 K to 6 K (+19.88 %) |
| Sep 13 2012 | CLH | CLEAN HARBORS INC | Gagnon Robert E. | EVP CFO and Treasur ... | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Mar 01 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Sell | S | 115.51 | 357 | 41,237 | 3,999 | 4.4 K to 4 K (-8.20 %) |
| Mar 01 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Sell | S | 115.51 | 360 | 41,584 | 4,356 | 4.7 K to 4.4 K (-7.63 %) |
| Mar 01 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Sell | S | 115.03 | 835 | 96,050 | 4,716 | 5.6 K to 4.7 K (-15.04 %) |
| Feb 27 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Option Exercise | M | 49.65 | 1,054 | 52,331 | 1,054 | |
| Feb 27 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Option Exercise | M | 0.00 | 1,223 | 0 | 2,446 | |
| Feb 27 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Payment of Exercise | F | 116.39 | 168 | 19,554 | 5,551 | 5.7 K to 5.6 K (-2.94 %) |
| Feb 27 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Payment of Exercise | F | 116.39 | 166 | 19,321 | 5,719 | 5.9 K to 5.7 K (-2.82 %) |
| Feb 27 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Sell | S | 115.53 | 1,054 | 121,769 | 5,885 | 6.9 K to 5.9 K (-15.19 %) |
| Feb 27 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Buy | M | 49.65 | 1,054 | 52,331 | 6,939 | 5.9 K to 6.9 K (+17.91 %) |
| Feb 27 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Payment of Exercise | F | 116.70 | 388 | 45,280 | 5,885 | 6.3 K to 5.9 K (-6.19 %) |
| Feb 27 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Buy | M | 0.00 | 1,223 | 0 | 6,273 | 5.1 K to 6.3 K (+24.22 %) |
| Feb 16 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Sell | S | 118.61 | 560 | 66,422 | 5,050 | 5.6 K to 5.1 K (-9.98 %) |
| Feb 13 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Option Exercise | M | 0.00 | 861 | 0 | 2,582 | |
| Feb 13 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Payment of Exercise | F | 117.78 | 301 | 35,452 | 5,610 | 5.9 K to 5.6 K (-5.09 %) |
| Feb 13 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Buy | M | 0.00 | 861 | 0 | 5,911 | 5.1 K to 5.9 K (+17.05 %) |
| Feb 10 2012 | IDPH | BIOGEN INC. | Gagnon Robert E. | Vice President, Fin ... | Option Exercise | A | 0.00 | 2,138 | 0 | 2,138 | |
| Dec 08 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 112.31 | 795 | 89,286 | 5,050 | 5.8 K to 5.1 K (-13.60 %) |
| Dec 02 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Payment of Exercise | F | 116.48 | 371 | 43,214 | 5,845 | 6.2 K to 5.8 K (-5.97 %) |
| Nov 14 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 112.04 | 796 | 89,184 | 6,216 | 7 K to 6.2 K (-11.35 %) |
| Nov 04 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Payment of Exercise | F | 113.43 | 371 | 42,083 | 7,012 | 7.4 K to 7 K (-5.03 %) |
| Oct 07 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 97.66 | 252 | 24,610 | 7,383 | 7.6 K to 7.4 K (-3.30 %) |
| Oct 04 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Option Exercise | M | 49.59 | 778 | 38,581 | 778 | |
| Oct 04 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 92.55 | 778 | 72,004 | 7,635 | 8.4 K to 7.6 K (-9.25 %) |
| Oct 04 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Buy | M | 49.59 | 778 | 38,581 | 8,413 | 7.6 K to 8.4 K (+10.19 %) |
| Oct 04 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Payment of Exercise | F | 93.15 | 118 | 10,992 | 7,635 | 7.8 K to 7.6 K (-1.52 %) |
| May 09 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 96.13 | 967 | 92,960 | 7,753 | 8.7 K to 7.8 K (-11.09 %) |
| May 04 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 96.03 | 215 | 20,646 | 8,720 | 8.9 K to 8.7 K (-2.41 %) |
| May 04 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Payment of Exercise | F | 97.99 | 450 | 44,096 | 8,935 | 9.4 K to 8.9 K (-4.79 %) |
| May 03 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Payment of Exercise | F | 97.65 | 101 | 9,863 | 9,385 | 9.5 K to 9.4 K (-1.06 %) |
| Mar 03 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 70.32 | 100 | 7,032 | 9,486 | 9.6 K to 9.5 K (-1.04 %) |
| Mar 03 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 69.98 | 616 | 43,109 | 9,586 | 10.2 K to 9.6 K (-6.04 %) |
| Mar 03 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 70.17 | 586 | 41,122 | 10,202 | 10.8 K to 10.2 K (-5.43 %) |
| Mar 03 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 69.02 | 100 | 6,902 | 10,788 | 10.9 K to 10.8 K (-0.92 %) |
| Feb 28 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Payment of Exercise | F | 67.26 | 168 | 11,300 | 10,888 | 11.1 K to 10.9 K (-1.52 %) |
| Feb 28 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Payment of Exercise | F | 67.26 | 167 | 11,232 | 11,056 | 11.2 K to 11.1 K (-1.49 %) |
| Feb 25 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Option Exercise | M | 49.65 | 1,054 | 52,331 | 2,108 | |
| Feb 25 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Option Exercise | J | 0.00 | 217 | 0 | 3,669 | |
| Feb 25 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Option Exercise | M | 0.00 | 191 | 0 | 3,886 | |
| Feb 25 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Option Exercise | M | 0.00 | 815 | 0 | 4,077 | |
| Feb 25 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 66.99 | 1,054 | 70,606 | 11,223 | 12.3 K to 11.2 K (-8.59 %) |
| Feb 25 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Buy | M | 49.65 | 1,054 | 52,331 | 12,277 | 11.2 K to 12.3 K (+9.39 %) |
| Feb 25 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Payment of Exercise | F | 66.76 | 61 | 4,072 | 11,223 | 11.3 K to 11.2 K (-0.54 %) |
| Feb 25 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Payment of Exercise | F | 66.76 | 259 | 17,291 | 11,284 | 11.5 K to 11.3 K (-2.24 %) |
| Feb 25 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Buy | M | 0.00 | 191 | 0 | 11,543 | 11.4 K to 11.5 K (+1.68 %) |
| Feb 25 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Buy | M | 0.00 | 815 | 0 | 11,352 | 10.5 K to 11.4 K (+7.73 %) |
| Feb 18 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 67.10 | 732 | 49,115 | 10,537 | 11.3 K to 10.5 K (-6.50 %) |
| Feb 15 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Payment of Exercise | F | 65.83 | 341 | 22,448 | 11,269 | 11.6 K to 11.3 K (-2.94 %) |
| Feb 11 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Option Exercise | A | 0.00 | 3,443 | 0 | 3,443 | |
| Jan 05 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Option Exercise | M | 49.65 | 1,053 | 52,281 | 3,162 | |
| Jan 05 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Option Exercise | M | 40.63 | 1,700 | 69,071 | 0 | |
| Jan 05 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Option Exercise | M | 49.59 | 1,554 | 77,063 | 1,556 | |
| Jan 05 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 66.57 | 1,053 | 70,101 | 10,814 | 11.9 K to 10.8 K (-8.87 %) |
| Jan 05 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Buy | M | 49.65 | 1,053 | 52,281 | 11,867 | 10.8 K to 11.9 K (+9.74 %) |
| Jan 05 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 66.55 | 1,700 | 113,141 | 10,814 | 12.5 K to 10.8 K (-13.58 %) |
| Jan 05 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Buy | M | 40.63 | 1,700 | 69,071 | 12,514 | 10.8 K to 12.5 K (+15.72 %) |
| Jan 05 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 66.58 | 1,554 | 103,459 | 10,814 | 12.4 K to 10.8 K (-12.56 %) |
| Jan 05 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Buy | M | 49.59 | 1,554 | 77,063 | 12,368 | 10.8 K to 12.4 K (+14.37 %) |
| Jan 05 2011 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 66.57 | 796 | 52,989 | 10,814 | 11.6 K to 10.8 K (-6.86 %) |
| Dec 07 2010 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Sell | S | 66.53 | 796 | 52,957 | 11,610 | 12.4 K to 11.6 K (-6.42 %) |
| Dec 03 2010 | IDPH | BIOGEN INC. | Gagnon Robert E. | Chief Acct Officer ... | Payment of Exercise | F | 65.37 | 371 | 24,252 | 12,406 | 12.8 K to 12.4 K (-2.90 %) |
Page: 1